40 related articles for article (PubMed ID: 16458425)
1. Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer.
Suzuki M; Shigematsu H; Shivapurkar N; Reddy J; Miyajima K; Takahashi T; Gazdar AF; Frenkel EP
Cancer Lett; 2006 Oct; 242(2):222-30. PubMed ID: 16458425
[TBL] [Abstract][Full Text] [Related]
2. Retraction notice to “Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer” [Cancer Lett. 242 (2) (2006) 222–230]. Makoto Suzuki, Hisayuki Shigematsu, Narayan Shivapurkar, Jyotsna Reddy, Kuniharu Miyajima, Takao Takahashi, Adi F. Gazdar, Eugene P. Frenke.
Cancer Lett; 2015 Apr; 360(1):87. PubMed ID: 25927107
[TBL] [Abstract][Full Text] [Related]
3. Decitabine enhances the tumoricidal potential of TRAIL via the epigenetic regulation of death receptor 4 in gastric cancer.
Li L; Niu Q; Zhu Y; Fan B; Yang G
J Gastrointest Oncol; 2022 Dec; 13(6):2799-2808. PubMed ID: 36636077
[TBL] [Abstract][Full Text] [Related]
4. STAT3 and STAT5 Activation in Solid Cancers.
Igelmann S; Neubauer HA; Ferbeyre G
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31557897
[TBL] [Abstract][Full Text] [Related]
5. Expression of SOCS1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract][Full Text] [Related]
6. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
7. TGF-β mediated DNA methylation in prostate cancer.
Lee C; Zhang Q; Zi X; Dash A; Soares MB; Rahmatpanah F; Jia Z; McClelland M; Mercola D
Transl Androl Urol; 2012 Jun; 1(2):78-88. PubMed ID: 25133096
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation and apoptosis resistance in cancer cells.
Hervouet E; Cheray M; Vallette FM; Cartron PF
Cells; 2013 Jul; 2(3):545-73. PubMed ID: 24709797
[TBL] [Abstract][Full Text] [Related]
9. Ras-induced epigenetic inactivation of the RRAD (Ras-related associated with diabetes) gene promotes glucose uptake in a human ovarian cancer model.
Wang Y; Li G; Mao F; Li X; Liu Q; Chen L; Lv L; Wang X; Wu J; Dai W; Wang G; Zhao E; Tang KF; Sun ZS
J Biol Chem; 2014 May; 289(20):14225-38. PubMed ID: 24648519
[TBL] [Abstract][Full Text] [Related]
10. Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation.
Cho Y; Turner ND; Davidson LA; Chapkin RS; Carroll RJ; Lupton JR
Exp Biol Med (Maywood); 2014 Mar; 239(3):302-10. PubMed ID: 24495951
[TBL] [Abstract][Full Text] [Related]
11. Expression of SOCSs in human prostate cancer and their association in prognosis.
Zhu JG; Dai QS; Han ZD; He HC; Mo RJ; Chen G; Chen YF; Wu YD; Yang SB; Jiang FN; Chen WH; Sun ZL; Zhong WD
Mol Cell Biochem; 2013 Sep; 381(1-2):51-9. PubMed ID: 23666742
[TBL] [Abstract][Full Text] [Related]
12. GATA4 and DcR1 methylation in glioblastomas.
Vaitkienė P; Skiriutė D; Skauminas K; Tamašauskas A
Diagn Pathol; 2013 Jan; 8():7. PubMed ID: 23320456
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-induced apoptosis and development of resistance are transcriptionally distinct processes.
Panaretakis T
Cell Cycle; 2012 Oct; 11(20):3723. PubMed ID: 22983001
[No Abstract] [Full Text] [Related]
14. Whole blood DNA aberrant methylation in pancreatic adenocarcinoma shows association with the course of the disease: a pilot study.
Dauksa A; Gulbinas A; Barauskas G; Pundzius J; Oldenburg J; El-Maarri O
PLoS One; 2012; 7(5):e37509. PubMed ID: 22629410
[TBL] [Abstract][Full Text] [Related]
15. Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity.
Xu M; Knox AJ; Michaelis KA; Kiseljak-Vassiliades K; Kleinschmidt-DeMasters BK; Lillehei KO; Wierman ME
Endocrinology; 2012 Jul; 153(7):2963-73. PubMed ID: 22562171
[TBL] [Abstract][Full Text] [Related]
16. Alterations of global histone H4K20 methylation during prostate carcinogenesis.
Behbahani TE; Kahl P; von der Gathen J; Heukamp LC; Baumann C; Gütgemann I; Walter B; Hofstädter F; Bastian PJ; von Ruecker A; Müller SC; Rogenhofer S; Ellinger J
BMC Urol; 2012 Mar; 12():5. PubMed ID: 22413846
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation in promoter region as biomarkers in prostate cancer.
Yang M; Park JY
Methods Mol Biol; 2012; 863():67-109. PubMed ID: 22359288
[TBL] [Abstract][Full Text] [Related]
18. CpG-island methylation study of liver fluke-related cholangiocarcinoma.
Sriraksa R; Zeller C; El-Bahrawy MA; Dai W; Daduang J; Jearanaikoon P; Chau-In S; Brown R; Limpaiboon T
Br J Cancer; 2011 Apr; 104(8):1313-8. PubMed ID: 21448164
[TBL] [Abstract][Full Text] [Related]
19. Global reactivation of epigenetically silenced genes in prostate cancer.
Ibragimova I; Ibáñez de Cáceres I; Hoffman AM; Potapova A; Dulaimi E; Al-Saleem T; Hudes GR; Ochs MF; Cairns P
Cancer Prev Res (Phila); 2010 Sep; 3(9):1084-92. PubMed ID: 20699414
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation changes in prostate cancer: current developments and future clinical implementation.
Hoque MO
Expert Rev Mol Diagn; 2009 Apr; 9(3):243-57. PubMed ID: 19379083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
